http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100739367-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
filingDate 2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100739367-B1
titleOfInvention Sulfamide derivatives and a composition for promoting fat metabolism containing the same
abstract The present invention relates to a novel sulfamide derivative of Formula 1, and a pharmaceutical composition for promoting fat metabolism containing the derivative or a pharmaceutically acceptable acid, salt or solvate thereof as an active ingredient, and a sulfa according to the present invention. The amide derivative may be usefully used for the development of therapeutic agents for diseases caused by fat metabolism syndrome X including obesity, diabetes mellitus (NIDDM), hyperlipidemia and arteriosclerosis, and fatty fatty acid, such as liver and muscle simple fatosis or fatty liver. . n n n <Formula 1>n n n n n n n n n Wheren n n R 1 to R 7 , X, Y, m and n are as defined in the specification.
priorityDate 2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004050640-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413967134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413972476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164005329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11706536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412243063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413366150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11533394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465799215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451468251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11678214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412243038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11721162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11657353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11685902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413366115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413956721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413972487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424099866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409922251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59003703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11497188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59003724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11613992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448346741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11526796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11577533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11612821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454241358

Total number of triples: 48.